Shanghai Aohua Photoelectricity Endoscope Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Aohua Photoelectricity Endoscope has a total shareholder equity of CN¥1.4B and total debt of CN¥88.3M, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are CN¥1.7B and CN¥279.3M respectively. Shanghai Aohua Photoelectricity Endoscope's EBIT is CN¥38.8M making its interest coverage ratio -6.9. It has cash and short-term investments of CN¥367.3M.
Key information
6.3%
Debt to equity ratio
CN¥88.27m
Debt
| Interest coverage ratio | -6.9x |
| Cash | CN¥367.28m |
| Equity | CN¥1.40b |
| Total liabilities | CN¥279.26m |
| Total assets | CN¥1.68b |
Recent financial health updates
Recent updates
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.'s (SHSE:688212) Price In Tune With Revenues
Dec 27
Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Might Be Having Difficulty Using Its Capital Effectively
Dec 04Earnings Troubles May Signal Larger Issues for Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Shareholders
Nov 01We Think Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Can Stay On Top Of Its Debt
Oct 18Estimating The Intrinsic Value Of Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (SHSE:688212)
Sep 29Shanghai Aohua Photoelectricity Endoscope Co., Ltd.'s (SHSE:688212) Earnings Haven't Escaped The Attention Of Investors
May 31We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings
Apr 16Here's Why Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Has Caught The Eye Of Investors
Mar 17Financial Position Analysis
Short Term Liabilities: 688212's short term assets (CN¥946.9M) exceed its short term liabilities (CN¥208.1M).
Long Term Liabilities: 688212's short term assets (CN¥946.9M) exceed its long term liabilities (CN¥71.1M).
Debt to Equity History and Analysis
Debt Level: 688212 has more cash than its total debt.
Reducing Debt: 688212's debt to equity ratio has increased from 0.2% to 6.3% over the past 5 years.
Debt Coverage: 688212's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 688212 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 10:37 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Bo Yu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |